STADA Group makes further investment in Serbian location

  • 6/8/2015

Bad Vilbel/Vršac, June 8, 2015 –

 STADA's Serbian subsidiary Hemofarm celebrated the opening of a state-of-the-art production and filling facility for ampoules in Vršac on Sunday, May 31, 2015. STADA has thus invested a total of approximately Euro 150 million in Serbia since the integration of the largest Serbian health company into the Group in 2006. The value of the new plant amounts to Euro 4.37 million.

"We are very proud of this new production facility with its equipment and technology of the highest international standard. We have thus once again strengthened one of our most important locations and our international competitiveness", says Hartmut Retzlaff, Chairman of the Executive Board at STADA. The opening of the new plant took place on the 55th anniversary of Hemofarm in the presence of the Serbian Prime Minister Aleksandar Vučić.
In the future, up to 75 million ampoules will be produced annually across a floor area of 600 square meters.
They are not intended for the Serbian home market only, but will be mostly exported. All production steps, from manufacturing to packaging the solutions, are carried out on site through 50 highly qualified employees.

For additional information, please contact:
STADA Arzneimittel AG
Media Relations
Stadastraße 2–18
61118 Bad Vilbel – Germany
Phone: +49 (0) 6101 603-165
Fax: +49 (0) 6101 603-215

Photos of the production in Serbia are available at our press center or on the Website of our Serbian subsidiary Hemofarm.